0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Adalimumab Biosimilar Market Expands with Increasing Adoption of Cost-Effective Biologic TherapiesAccording to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market A talented team works strictly with their potential capabilities to produce the most excellent Adalimumab Biosimilar Market research report. To give clear idea about the current and future marketplace, most up to date market insights and analysis has been offered...0 Комментарии 0 Поделились 742 Просмотры 0 предпросмотр
-
Adalimumab Biosimilar Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Demand for Cost-Effective Biologic Therapies and Expanding Biosimilar AdoptionAccording to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. This Adalimumab Biosimilar Marketdocument provides with...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Axial Spondyloarthritis Treatment Market Advances with Emerging Biologic Therapies and Personalized Care ApproachesAccording to the latest report published by Data Bridge Market Research, the Axial Spondyloarthritis Treatment Market The global axial spondyloarthritis treatment market size was valued at USD 4.58 billion in 2025and is expected to reach USD 8.39 billion by 2033, at a CAGR of 7.87% during the forecast period The persuasive Axial Spondyloarthritis Treatment Market report explains...0 Комментарии 0 Поделились 790 Просмотры 0 предпросмотр
-
Axial Spondyloarthritis Treatment Market Expands with Advances in Biologic Therapies and Personalized Care for Inflammatory DisordersAccording to the latest report published by Data Bridge Market Research, the Axial Spondyloarthritis Treatment Market The global axial spondyloarthritis treatment market size was valued at USD 4.58 billion in 2025and is expected to reach USD 8.39 billion by 2033, at a CAGR of 7.87% during the forecast period The data, information, statistics, facts and figures covered in this...0 Комментарии 0 Поделились 838 Просмотры 0 предпросмотр
-
Global Dupilumab Drug Market Expected to Reach USD 34.94 Billion by 2032 Amid Rising Demand for Advanced Biologic TherapiesAccording to a report by Intel Market Research, the global Dupilumab Drug Market was valued at USD 16,960 million in 2024 and is projected to reach USD 34,940 million by 2032, registering a CAGR of 11.2% during the forecast period. The market is experiencing substantial growth driven by the increasing prevalence of chronic inflammatory diseases, expanding regulatory approvals, growing adoption...0 Комментарии 0 Поделились 658 Просмотры 0 предпросмотр
-
Stem Cell-Derived Biologic Therapies Market Intelligence Report with Emerging Trends"Stem Cell-Derived Biologic Therapies Market Summary According to the latest report published by Data Bridge Market Research, the Stem Cell-Derived Biologic Therapies Market The global stem cell-derived biologic therapies market size was valued at USD 5.21 billion in 2025 and is expected to reach USD 16.38 billion by 2033, at a CAGR of 15.40% during the...0 Комментарии 0 Поделились 767 Просмотры 0 предпросмотр
-
Stem Cell-Derived Biologic Therapies Market Intelligence Report with Emerging Trends"Stem Cell-Derived Biologic Therapies Market Summary According to the latest report published by Data Bridge Market Research, the Stem Cell-Derived Biologic Therapies Market The global stem cell-derived biologic therapies market size was valued at USD 5.21 billion in 2025 and is expected to reach USD 16.38 billion by 2033, at a CAGR of 15.40% during the...0 Комментарии 0 Поделились 833 Просмотры 0 предпросмотр
-
Stem Cell-Derived Biologic Therapies Market Size, Share & Growth Forecast 2033"Stem Cell-Derived Biologic Therapies Market Summary According to the latest report published by Data Bridge Market Research, the Stem Cell-Derived Biologic Therapies Market The global stem cell-derived biologic therapies market size was valued at USD 5.21 billion in 2025 and is expected to reach USD 16.38 billion by 2033, at a CAGR of 15.40% during the...0 Комментарии 0 Поделились 255 Просмотры 0 предпросмотр
-
The Rise of Biologic Therapies in Veterinary Medicine: Market Trends and Strategic Insightsv Modern veterinary medicine is undergoing an unprecedented paradigm shift. For decades, managing chronic illnesses in companion animals and livestock relied almost exclusively on small-molecule pharmaceuticals, corticosteroids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and traditional broad-spectrum antibiotics. While effective, these therapies frequently carry a heavy burden of systemic...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
X Linked Hypophosphatemia (XLH) Treatment Market to Grow on Rising Adoption of Targeted Biologic Therapies" According to the latest report published by Data Bridge Market Research, the X Linked Hypophosphatemia (XLH) Treatment Market CAGR Value Data Bridge Market Research analyses a growth rate in the X linked hypophosphatemia (XLH) treatment market in the forecast period 2023-2030. The expected CAGR of X linked hypophosphatemia (XLH) treatment market tend to be around 10% in the...0 Комментарии 0 Поделились 206 Просмотры 0 предпросмотр
-
Retinal Biologics Market to Reach USD 43.98 Billion by 2033, Growing at 6.75% CAGRRetinal Biologics Market Overview The global retinal biologics market size was valued at USD 24.43 billion in 2024 and is projected to grow from USD 26.08 billion in 2025 to USD 43.98 billion by 2033, growing at a CAGR of 6.75% during the forecast period (2025-2033). Download Exclusive Research Report PDF Sample: (Including...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Rising Demand for Orthopedic Drugs Drives Market Growth at 4.7% CAGR Through 2034According to a new report from Intel Market Research, the global prescription orthopedic drugs market was valued at USD 5.8 billion in 2025 and is projected to reach USD 9.1 billion by 2034, growing at a steady CAGR of 4.7% during the forecast period (2026–2034). This sustained growth reflects an aging global population's increasing need for musculoskeletal treatments and continuous...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek